Literature DB >> 2727901

Cholesterol embolism: experience with 22 histologically proven cases.

P J Dahlberg1, D F Frecentese, T H Cogbill.   

Abstract

The records of 22 patients, aged 61 to 85 years, with histologically proven cholesterol embolism (CE) were reviewed. All had one or more risk factors. Twenty-one patients had preexisting symptomatic or recognized atherosclerotic disease. Twenty patients had one or more identifiable precipitating factors, including warfarin administration (4), angiography (15), angioplasty (2), intra-aortic balloon pump placement (2), vascular surgery (11), aortitis (2), and cardiopulmonary resuscitation (1). These preceded the onset of symptoms by as many as 3 months, but usually by less than 3 weeks. Eight patients had peripheral CE alone. Fourteen patients had visceral CE. All 14 had renal CE that was characterized by abrupt deterioration of renal function after a precipitating event (13), evidence of concurrent CE to the lower extremities or other organs (10), accelerated hypertension (9), gross hematuria (6), or flank and back pain (3). Unusual presentations included one case each of spinal cord infarction, penile gangrene, adrenal insufficiency, and symptomatic splenic infarct. If patients with visceral CE survived after initial hospitalization, they often required dialysis and later hospitalizations because of complications. Premortem diagnoses were made in 18 patients: nine from surgical specimens and nine from biopsies (one kidney, eight muscle and skin). Attempts at definitive vascular surgery were possible in only two patients and successful in one. The challenges encountered in managing these patients' conditions are reviewed.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2727901

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  16 in total

1.  Lesson of the week: cholesterol emboli syndrome.

Authors:  P J Dupont; L Lightstone; E J Clutterbuck; G Gaskin; C D Pusey; T Cook; A N Warrens
Journal:  BMJ       Date:  2000-10-28

2.  Cholesterol emboli syndrome--uncommon or unrecognized?

Authors:  S P Bell; A Frankel; E A Brown
Journal:  J R Soc Med       Date:  1997-10       Impact factor: 5.344

3.  Atheroembolism.

Authors:  John S. Smyth; John E. Scoble
Journal:  Curr Treat Options Cardiovasc Med       Date:  2002-06

4.  Recurrent anaemia due to ischaemic colonic ulceration caused by cholesterol embolism.

Authors:  D J Grant; D S Sanders; M E McMurdo; M H Lyall
Journal:  Postgrad Med J       Date:  1993-04       Impact factor: 2.401

5.  Investigation of the thoracic aorta in cholesterol embolism by transoesophageal echocardiography.

Authors:  E Ferrari; B Taillan; E Drai; P Morand; M Baudouy
Journal:  Heart       Date:  1998-02       Impact factor: 5.994

Review 6.  Cholesterol embolisation after thrombolytic therapy.

Authors:  J C Blankenship
Journal:  Drug Saf       Date:  1996-02       Impact factor: 5.606

Review 7.  Aortic arch plaque in stroke.

Authors:  Souvik Sen
Journal:  Curr Cardiol Rep       Date:  2009-01       Impact factor: 2.931

Review 8.  Secondary hypertension. An overview of its causes and management.

Authors:  D H Streeten; G H Anderson
Journal:  Drugs       Date:  1992-06       Impact factor: 9.546

Review 9.  Coumarin-induced skin necrosis. Incidence, mechanisms, management and avoidance.

Authors:  P C Comp
Journal:  Drug Saf       Date:  1993-02       Impact factor: 5.606

10.  Cholesterol crystal embolization to liver, gallbladder, and pancreas.

Authors:  W Moolenaar; C B Lamers
Journal:  Dig Dis Sci       Date:  1996-09       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.